New insights into statin-intolerance: biopsychosocial differences, medication beliefs, trust in healthcare and treatment decisions in statin-intolerant versus statin-tolerant patients [0.03%]
他汀类药物不耐受的新见解：他汀类药物不耐受和耐受患者在生物心理社会差异、药物信念、对医疗保健的信任和治疗决策方面的差异
Ruben J M Mijnster,Neivyn Shaheen,Wim J R Rietdijk et al.
Ruben J M Mijnster et al.
Aims: This study examined biopsychosocial differences between statin-intolerant and statin-tolerant patients, including their medication beliefs, healthcare trust and influential factors for treatment decisions. ...
Sex Differences in Trajectories of LDL Cholesterol Control in Chronic Coronary Syndromes [0.03%]
慢性冠状动脉综合征患者LDL胆固醇水平控制的性别差异轨迹研究
Jules Mesnier,Louis Giovachini,Gregory Ducrocq et al.
Jules Mesnier et al.
Background and aims: Sex differences in the longitudinal evolution of low-density lipoprotein cholesterol (LDL-C) management among patients with chronic coronary syndromes (CCS) are not well known. ...
Longitudinal changes of cardiorespiratory fitness are associated with cardiovascular disease and mortality: evidence from the UK Biobank [0.03%]
来自英国生物样本库的心肺功能纵向变化与心血管疾病和死亡率相关性的证据
Rubén López-Bueno,Lars Louis Andersen,Ana Polo-López et al.
Rubén López-Bueno et al.
Aims: Cardiorespiratory fitness (CRF) is a strong predictor of cardiovascular disease (CVD) and mortality. However, whether longitudinal changes in CRF independently predict cardiovascular outcomes beyond baseline CRF rem...
Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity [0.03%]
肥胖人群用于 primary prevention of cardiovascular disease 的 Tirzepatide 使用三年对预测心血管疾病十年风险的降低作用
Naveed Sattar,Mamas Mamas,Runjia Li et al.
Naveed Sattar et al.
Aim: This post hoc analysis assessed the durability of tirzepatide for primary cardiovascular disease (CVD) prevention in obesity, based on predicted CVD risk, in the SURMOUNT-1 (SM-1) 3-year study. ...
When cardiometabolic risk meets myocardial vulnerability in the female heart [0.03%]
心血管代谢危险因素与女性心脏肌体脆弱性之间的关系
Jennifer H Mieres,Kumar Sarkar,Amgad N Makaryus
Jennifer H Mieres
Heart Failure Prevention in Central Adiposity and Preclinical Left Ventricular Systolic Impairment [0.03%]
中央型肥胖和左心室收缩功能不全前心力衰竭的预防
Matthew M Y Lee,Carolyn S P Lam
Matthew M Y Lee
Body mass index and major cardiovascular events after myocardial infarction: A nationwide registry study [0.03%]
体质指数与心肌梗死后主要心血管事件的关系：一项基于全国登记数据的研究
Peder Af Geijerstam,Pontus Hedberg,Nermin Hadziosmanovic et al.
Peder Af Geijerstam et al.
Aim: The "obesity paradox" suggests lower cardiovascular risk at higher body mass index (BMI) after myocardial infarction (MI), but whether it reflects true protection or methodological bias is unclear. ...
Rethinking how we characterize the exercise blood pressure response in athletes [0.03%]
重新考虑我们对运动员运动血压反应的特征方法
Gabriel S Romano,Natalie Miners,Philip J Millar
Gabriel S Romano
From Selye to ZEUS: inflammation as the adaptation syndrome's hidden machinery [0.03%]
从塞莱到ZEUS：炎症作为适应综合征的隐藏机器
Emilton Lima Junior,Fabiola Welter Ribeiro
Emilton Lima Junior